These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS. Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049 [TBL] [Abstract][Full Text] [Related]
24. The PI3K/Akt pathway contributes to arenavirus budding. Urata S; Ngo N; de la Torre JC J Virol; 2012 Apr; 86(8):4578-85. PubMed ID: 22345463 [TBL] [Abstract][Full Text] [Related]
25. Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Kunz S; Sevilla N; Rojek JM; Oldstone MB Virology; 2004 Aug; 325(2):432-45. PubMed ID: 15246281 [TBL] [Abstract][Full Text] [Related]
26. Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes. Iwasaki M; Urata S; Cho Y; Ngo N; de la Torre JC Virology; 2014 Jun; 458-459():22-32. PubMed ID: 24928036 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. Martínez-Sobrido L; Zúñiga EI; Rosario D; García-Sastre A; de la Torre JC J Virol; 2006 Sep; 80(18):9192-9. PubMed ID: 16940530 [TBL] [Abstract][Full Text] [Related]
28. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library. Lan X; Zhang Y; Jia X; Dong S; Liu Y; Zhang M; Guo J; Cao J; Guo Y; Xiao G; Wang W Antiviral Res; 2022 Jan; 197():105230. PubMed ID: 34965446 [TBL] [Abstract][Full Text] [Related]
31. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors. Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302 [TBL] [Abstract][Full Text] [Related]
32. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Sullivan BM; Emonet SF; Welch MJ; Lee AM; Campbell KP; de la Torre JC; Oldstone MB Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2969-74. PubMed ID: 21270335 [TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV. Hastie KM; Igonet S; Sullivan BM; Legrand P; Zandonatti MA; Robinson JE; Garry RF; Rey FA; Oldstone MB; Saphire EO Nat Struct Mol Biol; 2016 Jun; 23(6):513-521. PubMed ID: 27111888 [TBL] [Abstract][Full Text] [Related]
34. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Pinschewer DD; Perez M; Sanchez AB; de la Torre JC Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7895-900. PubMed ID: 12808132 [TBL] [Abstract][Full Text] [Related]
35. A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein. Iwasaki M; de la Torre JC J Virol; 2018 Jun; 92(11):. PubMed ID: 29593035 [TBL] [Abstract][Full Text] [Related]
39. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Emonet SE; Urata S; de la Torre JC Virology; 2011 Mar; 411(2):416-25. PubMed ID: 21324503 [TBL] [Abstract][Full Text] [Related]
40. Analysis of the Function of the Lymphocytic Choriomeningitis Virus S Segment Untranslated Region on Growth Capacity In Vitro and on Virulence In Vivo. Taniguchi S; Yoshikawa T; Shimojima M; Fukushi S; Kurosu T; Tani H; Fukuma A; Kato F; Nakayama E; Maeki T; Tajima S; Lim CK; Ebihara H; Kyuwa S; Morikawa S; Saijo M Viruses; 2020 Aug; 12(8):. PubMed ID: 32824338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]